Study to Determine How BCX4161 is Metabolized and Eliminated by the Body
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hereditary Angioedema
Related studies linked through entity extraction aliases.
Hereditary AngioEdema, Neurobiology and Psychopathology
- Status
- UNKNOWN
- Phase
- N/A
A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE
- Status
- COMPLETED
- Phase
- PHASE2
A Call Center During HAE Attacks (SOS HAE)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase
- Status
- COMPLETED
- Phase
- PHASE2
C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
- Status
- COMPLETED
- Phase
- N/A
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
- Status
- COMPLETED
- Phase
- PHASE3
C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
- Status
- COMPLETED
- Phase
- PHASE2
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
- Status
- COMPLETED
- Phase
- PHASE3
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration
- Status
- COMPLETED
- Phase
- PHASE2
Berinert P Study of Subcutaneous Versus Intravenous Administration
- Status
- COMPLETED
- Phase
- PHASE3
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
- Status
- COMPLETED
- Phase
- PHASE3